Cancer Clinical Trial -HonorHealth Research Institute-Incyte-54828-19-05

Cancer

Status:

Open

ClinicalTrials.gov:

NCT05216120

Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas

Drug

Pemigatinib

Phase

Phase II

Condition

Pancreatic Adenocarcinoma

Keywords

Adenosquamous